Ключевые слова
Как цитировать
Аннотация
Проведен аналитический обзор исследований в области эпидемиологии и канцерогенеза рака шейки матки (РШМ) и мер и технологий профилактики этой формы рака. Рассмотрены данные об основных доказанных факторах риска РШМ, которыми являются определенные характеристики сексуального поведения и репродуктивного анамнеза, половые инфекции и инфицированность вирусом папилломы человека (ВПЧ), табакокурение и некоторые другие характеристики образа жизни. На данных мировой литературы проведен анализ существующих методов профилактики РШМ, включая адресный санпросвет, вакцинацию от ВПЧ и разные виды скрининга на РШМ. Приведены данные о значимости, эффективности и доступности разных профилактических технологий.
Библиографические ссылки
Бохман Я.В. Лекции по онкогинекологии. -М.: ООО «Медицинское информационное агентство», 2007. -304 с.
Гаспарян С.А., Овчинникова О.С. Оптимизация противовирусной терапии инозин пранобексом начальных поражений ВПЧ-ассоциированнных заболеваний шейки матки//Акушерство и Гинекология. -2015. -№ 9. -С. 94-97.
Джемал А., Винеис П., Брей Ф., Торре Л., Форман Д. (редакция) Атлас по онкологии. Издание второе. -Атланта, штат Джорджия: Американское онкологическое общество, 2014 г.
Евстигнеева Н.П. Папилломавирусная инфекция урогенитального тракта женщин: эпидемиология, факторы персистенции, оптимизация ранней диагностики и профилактики онкогенеза//Дис..докт. мед. наук. -Москва, 2007. -242 с.
Завельская А.Я., Табакокурение как управляемый фактор риска рака шейки матки. Дис..канд. мед. наук. -Москва, 2014. -157 с.
Завельская А.Я., Сырцова Л.Е., Левшин В.Ф. Пассивная экспозиция к табачному дыму из окружающей среды и риск развития рака шейки матки//Наркология. -2015. -Т. 167. -№ 11. -С. 52-56.
Заридзе Д.Г. Профилактика рака. Руководство для врачей. -М.:МА-ПРЕСС, 2009. -224 с.
Заридзе Д.Г. Табак -основная причина рака. -М.: ИМА-ПРЕСС, 2012. -208 с. -8
Злокачественные новообразования в России в 2013 году (заболеваемость и смертность)./Под редакцией Каприна А.Д., Старинского В.В., Петровой Г.В. -М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России. -2015. -ил. 250 с.
Киселев В.И. Вирусы папилломы человека в развитии рака шейки матки. -М., 2004.-184 с.
Киселева В.И., Крикунова Л.И. Мкртян Л.С. и др. Риск трансформации неопластических процессов шейки матки//Вопр. Онкол. -2014. -Т. 60. -С. 348-351.
Мировая статистика здравоохранения 2010 год. ВОЗ. -Женева, 2010. -С. 102-109.
Наумкина Т.Н. Папилломавирусная инфекция шейки матки у сексуально активных девушек-подростков (особенности течения, диагностики и лечения): Дис. канд. мед. наук. -Смоленск, 2004. -141 с.
Новик В.И. Эпидемиология рака шейки матки, факторы риска, скрининг//Практическая онкогинекология: Избранные лекции/Под редакцией У.Ф. Урманчеевой, С.А. Тюляндина, В.М. Моисеенко. -Санкт-Петербург: Центр ТОММ, 2008. -С. 101-115.
Подзолкова Н.М., Созаева Л.Г., Осадчев В.Б. Папилло-мавирусная и герпетическая инфекции в акушерстве и гинекологии//Учебно-методическое пособие. -М.:, 2007. -46 с.
Прилепская В.Н., Назарова Н.М., Мзареула Г.М. и др. ВПЧ-ассоциированные заболевания шейки матки -новое в диагностике//Акушерство и Гинекология. -2015. -№ 9. -С. 20-26.
Федеральный закон № 323, 2013; Постановление Правительства Российской Федерации от 31 декабря 2009 г. №1157.
de Abreu A.L., Malaguti N., Souza R.P et al. Association of human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis co-infections on the risk of high-grade squamous intraepithelial cervical lesion//Am. J. Cancer Res. -2016. -Vol. 6 (6). -P. 1371-1383.
Almonte M., Murillo R., S nchez G.I. et al. New paradigms and challenges in cervical cancer prevention and control in Latin America]//Salud. Publica Mex. -2010. -Vol. 52 (6). -P. 544-559.
Appleby P, Beral V., Berrington de Gonzlez A. et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies//Int. J. Cancer. -2006. -Vol. 118 (6). -P. 1481-1495.
Appleby P, Beral V., Berrington de Gonzlez A. et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies//Lancet. -2007. -Vol. 370 (9599). -Р 1609-1621.
Ayatollahi H., Homaei-Shandiz F., Kooshyar M.M. et al. Human papilloma virus 16/18 genotypes in patients with squamous cell carcinoma of cervix in northeast Iran//Niger Med. J. -2014. -Vol. 55 (6). -P. 495-498.
Bassal R., Schejter E., Bachar R. et al. Risk Factors for Cervical Cancer and CIN3 in Jewish Women in Israel -Two Case Control Studies//Asian Pac. J. Cancer Prev. -2016. -Vol. 17 (4). -P 2067-2073.
Bezabih M., Tessema F., Sengi H., Deribew A. Risk Factors Associated with Invasive Cervical Carcinoma among Women Attending Jimma University Specialized Hospital, Southwest Ethiopia: A Case Control Study//Ethiop J. Health Sci. -2015. -Vol. 25 (4). -P. 345-352.
Boldrini N.T., Freitas L.B., Coutinho A.R. et al. High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods//PLoS One. -2014. -Vol. 9 (7). -e102169.
Bosch F., Burchell A., Schiffman M. et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia//Vaccine. -2008. -Vol. 26 (10). -P 1-16.
Cancer Incidence in Five Continents Vol. 9//International Agency for Research on Cancer (WHO), 2009.
Castanon A., Landy R., Sasieni P By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?//J. Med. Screen. -2016. -pii: 0969141316654197.
Castle PE., Wacholder S., Lorincz A.T et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women//J. Natl. Cancer Inst. -2002. -Vol. 94 (18). -P 1406-1414.
Dugu PA., Rebolj M., Garred P. et al. Immunosuppression and risk of cervical cancer.//Expert. Rev. Anticancer Ther. -2013. -Vol. 13 (1). -Р 29-42.
Fiore M.C., Bailey W.C., Cohen S.J. et al. Treat in Tobacco Use and Dependence. Clinical Practice Guideline. -Rockville, MD. United States Department of Health and Human Services, Public Health service, 2000.
Franco E., Harper D.M. Vaccination against Human papillomavirus infection: a new paradigm in cervical cancer control//Vaccine. -2005. -Vol. 23. -Р 23882394.
Fujita M., Tase T, Kakugava Y et al. Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: a case-control study//Tohoku J. Exp. Med. -2008. -Vol. 216 (4). -Р 297-307.
Gadducci A., Barsotti C., Cosoio S. et al. Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature//Gynecol. Endocrinol. -2011. -Р. 23-27.
Gawdzik D., Chmaj-Wierzchowska K., Jurczyk M.U. Knowledge assessment of women living in the Wielkopolska region concerning risk factors for cervical cancer//Prz. Menopauzalny. -2015. -Vol. 14 (1). -P. 7-12. - DOI: 10.5114/pm.2015.48686
Guardado-Estrada M., Ju rez-Torres E., Rom n-Bassaure E. et al. The distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancer//PLoS One. -2014. -Vol. 9 (10). -e109406.
Hofstetter A.M., Ompad D.C., Stockwell M.S. et al. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females//JAMA Pediatr. -2016. -Vol. 170 (5). -Р 445-452.
Jensen K.E., Schmiedel S., Frederiksen К. et al. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection//Cancer Epidemiol. Biomarkers Prev. -2012. -Vol. 21 (11). -Р 1949-1955.
Jiang Y, SY Hu, Hernandez Donoso L. et al. A Systematic Literature Review on Risk Factors for Cervical Cancer in Chinese Population//Value in Health. -2014. -Vol. 17. -Issue 7. -P. A733-A734.
Jing L., Zhong X., Zhong Z. et al. Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women//Sex. Transm. Dis. -2014. -Vol. 41 (12). -P 732-738.
Joura E.A., Ault K.A., Bosch F.X. et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease//Cancer Epidemiol. Biomarkers. Prev. -2014. -Vol. 23 (10). -P. 1997-2008.
Kamineni A., Weinmann S., Shy K.K. et al. Efficacy of screening in preventing cervical cancer among older women//Cancer Causes Control. -2013. -Vol. 24 (9). -Р 1653-1660.
Kapeu A.S., Luostarinen T, Jellum E. et al. Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks//American Journal of Epidemiology. -2009. -Vol. 169 (4). -Р. 480-488.
Levin C.E., Sharma M., Olson Z. et al. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China//Vaccine. -2015. -Vol. 33 (24). -P 2830-2841.
Lew J.B., Simms K., Smith M. et al. Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand//PLoS One. -2016. -Vol. 11 (5). -e0151619. -doi: 10.1371.
Li W., Wang D.Z., Shen C.F. et al. Incidence trends of cervical cancer in Tianjin, 2007-2013. -2016. -Vol. 37 (5). -P 699-701.
Lindstrm A.K., Hellberg D. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infec-tion, smoking and patient outcome//Eur. J. Histochem. -2014. -Vol. 58 (2). -Р 2227.
Liu Z.C., Liu W.D., Liu YH. et al. Multiple Sexual Partners as a Potential Independent Risk Factor for Cervical Cancer: a Meta-analysis of Epidemiological Studies//Asian Pac. J. Cancer Prev. -2015. -Vol. 16 (9). -P 3893-3900.
Liu B., Wu Z.N., Liu X.Y. et al. Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdis-section(LCM)//Zhonghua Zhong Liu Za Zhi. -2016. -Vol. 38 (4). -P. 277-282.
Louvanto K., Syrjanen K.J., Rintala M.A. et al. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study//Acta. Obstet. Gynecol. Scand. -2011. -Vol. 90 (2). -P. 167-173.
Luhn P., Walker J., Schiffman M. et al. The role of co-factors in the progression from human papillomavirus infection to cervical cancer.//Gynecol Oncol. -2013. -Vol. 128 (2). -Р 265-270.
Matsumoto K., Yoshikawa H. Human papillomavirus infection and the risk of cervical cancer in Japan//J. Obstet. Gynaecol. Res. -2013. -Vol. 39 (1). -Р 7-17.
McCann M.F., Irwin D.E., Walton L.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers//Cancer Epidemiol. Biomarkers Prev. -1992. -Vol. 1. -№ 2. -P. 125-129.
Monsonego J., Zerat L., Syrjnen K. et al. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV Vaccines//Vaccine. -2012. -Vol. 30 (35). -Р 5215-5221.
Moosa K., Alsayyad A.S., Quint W. et al. An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain//BMC Cancer. -2014. -Vol. 14. -P905.
Nadarzynski T., Waller J., Robb K.A. et al. Perceived risk of cervical cancer among pre-screening age women (18-24 years): the impact of information about cervical cancer risk factors and the causal role of HPV//Sex Transm. Infect. -2012. -Vol. 88 (6). -Р 400-406.
Natphopsuk S., Settheetham-Ishida W., Sinawat S. et al. Risk factors for cervical cancer in northeastern Thailand: detailed analyses of sexual and smoking behavior//Asian. Pac. J. Cancer Prev. -2012. -Vol. 13 (11). -Р 5489-5495.
Oh H.Y., Seo S.S., Kim M.K. et al. Synergistic effect of viral load and alcohol consumption on the risk of persistent high-risk human papillomavirus infection//PLoS One. -2014. -Vol. 9 (8). -e104374. -doi: 10.1371.
Oh H.Y., Kim M.K., Seo S.S., Lee J.K. Association of Combined Tobacco Smoking and Oral Contraceptive Use With Cervical Intraepithelial Neoplasia 2 or 3 in Korean Women//J. Epidemiol. -2016. -Vol. 26 (1). -P. 22-29.
Ports K.A., Reddy D.M., Rameshbabu A. Barriers and facilitators to HPV vaccination: perspectives from Malawian women//Women Health. -2013. -Vol. 53 (6). -P. 630-645. - DOI: 10.1080/03630242.2013.809046
Ribeiro AA, Costa MC, Alves RR, et al. HPV infection and cervical neoplasia: associated risk factors//Infect Agent Cancer. -2015. -Vol. 10. -P 16.
Roura E., Castellsagu X., Pawlita M. et al. Smoking as a major risk factor for cervical cancer and precancer: results from the EPIC cohort//Int. J. Cancer. -2014. -Vol. 135 (2). -P. 453-466.
Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer//J. Natl. Cancer Inst. -2011. -Vol. 103 (5). -P. 368-383.
Seo S.S., Oh H.Y., Lee J.K.et al. Combined effect of diet and cervical microbiome on the risk of cervical intraepithelial neoplasia//Clin. Nutr. -2016. -pii: S0261-5614(16)30007-3.
Smith J.S., Lindsay L., Hoots B. еt al. Human papillomavirus type distribution in invas cancer and high-grade cervical lesions: A meta-analysis update//Int. J. Cancer. -2007. -Vol. 121. -P. 621-632.
Stanley M. Practitioner's Guide to understanding immunity to human papillomavirus.//US Obstet. Gynecol. -2009. -Vol. 4 (1). -Р 10-15.
Syrjanen K., Shabalova I., Sarian L. et al. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models//Eur. J. Gynecol. Oncol. -2012. -Vol. 33 (1). -Р 5-14.
Szender J.B., Cannioto R., Gulati N.R. et al. Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study//J. Low Genit. Tract. Dis. -2016. .
Tabrizi S.N., Brotherton J.M., Stevens M.P. et al. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program//J. Clin. Virol. -2014. -Vol. 60 (3). -P 250-256.
Tan S.C., Ankathil R. Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-re-lated genes//Tumour Biol. -2015. -Vol. 36 (9). -P. 6633-6644.
Thakur A., Gupta B., Gupta A., Chauhan R. Risk factors for cancer cervix among rural women of a hilly state: a case-control study//Indian J. Public. Health. -2015. -Vol. 59 (1). -P. 45-48.
Tomita L.Y, Roteli-Martins C.M., Villa L.L. et al. Associations ofdietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking//Br. J. Nutr. -2010. -Р 1-9.
Troisi R., Hatch E.E., Palmer J.R. et al. Prenatal di-ethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital trac//Am. J. Obstet. Gynecol. -2016. -pii: S0002-9378(16)00469-5.
Waggoner S.E., Darcy K.M., Fuhrman B. et al. Gynecologic Oncology Group. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study//Gynecol. Oncol. -2006. -Vol. 103 (3). -P. 853-858.
Wei L., Griego A.M., Chu M., Ozbun M.A. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes//Carcinogenesis. -2014. -Vol. 35 (10). -P. 2373-2381. - DOI: 10.1093/carcin/bgu156
Yang X., Xu J., Cheng X. et al. Distribution of human papillomavirus genotypes in early-stadge cervical adenocarcinoma and its clinical significance//Zhonghua Yi Xue Za Zhi. -2014. -Vol. 94 (45). -P. 3583-3585.
Yoruk S., Agkgoz A., Ergor G. Determination of knowledge levels, attitude and behaviors of female university students concerning cervical cancer, human papiloma virus and its vaccine//BMC Womens Health. -2016. -Vol. 16. -P. 51. - DOI: 10.1186/s12905-016-0330-6
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2017